Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentation

被引:10
|
作者
Anastasaki, Corina [1 ]
Rensing, Nicholas [1 ]
Johnson, Kevin J. [1 ]
Wong, Michael [1 ]
Gutmann, David H. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
关键词
encephalopathy; NREM sleep; sleep disturbance; sleep fragmentation; UNDERLIES; DEFICITS; CHILDREN;
D O I
10.1111/jsr.12816
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofibromatosis type 1 (NF1) is a neurodevelopmental disorder in which affected children and adults are at a higher risk of sleep disorders. In an effort to identify potential sleep disturbances in a small animal model, we used a previously reported Nf1 conditional knockout (Nf1(CKO)) mouse strain. In contrast to Nf1 mutant flies, the distribution of vigilance states was intact in Nf1(CKO) mice. However, Nf1(CKO) mice exhibited increased non-REM sleep (NREM)-to-wake and wake-to-NREM transitions. This sleep disruption was accompanied by decreased bout durations during awake and NREM sleep states under both light and dark conditions. Moreover, Nf1(CKO) mice have higher percentage delta power during awake and NREM sleep states under all light conditions. Taken together, Nf1(CKO) mice phenocopy some of the sleep disturbances observed in NF1 patients and provide a tractable platform to explore the molecular mechanisms governing sleep abnormalities in NF1.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] The role of the neurofibromatosis type 1 (NF1) gene in tumorigenesis
    Upadhyaya, M
    [J]. BRAIN PATHOLOGY, 2000, 10 (04) : 599 - 600
  • [22] Bony orbital morphology in neurofibromatosis type 1 (NF1)
    Kaste, SC
    Pivnick, EK
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (08) : 628 - 631
  • [23] Orbitotemporal facial involvement in type 1 neurofibromatosis (NF1)
    Rilliet, B.
    Pittet, B.
    Montandon, D.
    Narata, A. -P.
    de Ribaupierre, S.
    Schils, F.
    Boscherini, D.
    Di Rocco, C.
    Ducrey, N.
    [J]. NEUROCHIRURGIE, 2010, 56 (2-3) : 257 - 270
  • [24] An Illustrative Case of Neurofibromatosis Type 1 and NF1 Microdeletion
    Praxedes, L. A.
    Pereira, F. M.
    Mazzeu, J. F.
    Costa, S. S.
    Bertola, D. R.
    Kim, C. A.
    Vianna-Morgante, A. M.
    Otto, P. A.
    [J]. MOLECULAR SYNDROMOLOGY, 2010, 1 (03) : 133 - 135
  • [25] Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma?
    Evans, D. Gareth R.
    Lunt, Lauren
    [J]. AME CASE REPORTS, 2022, 6
  • [26] Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland
    Poyhonen, M
    Kytöla, S
    Leisti, J
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (08) : 632 - 636
  • [27] Pulmonary sarcoma complicated with neurofibromatosis type 1 (NF1)
    Abe, Y
    Hatanaka, H
    Kamiya, T
    Yamazaki, H
    Kijima, H
    Inoue, H
    Ueyama, Y
    Nakamura, M
    [J]. ANTICANCER RESEARCH, 2003, 23 (1B) : 613 - 616
  • [28] Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma?
    Evans, D. Gareth R.
    Lunt, Lauren
    [J]. AME CASE REPORTS, 2022, 6
  • [29] Mapping the neurobehavioural phenotypes of Type 1 Neurofibromatosis (NF1)
    Concialdi, C.
    Kirk, Claire W.
    Lydon, S.
    Healy, O.
    Green, A.
    Lynch, S. A.
    McVeigh, T. P.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 2) : 75 - 75
  • [30] ADULT BRAINSTEM GLIOMAS IN NEUROFIBROMATOSIS TYPE 1 (NF1)
    Guillamo, J.
    Wang, A.
    Ducray, F.
    Barbarot, S.
    Chinot, O.
    Frappaz, D.
    Bauchet, L.
    Wolkenstein, P.
    Laigle-Donadey, F.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 74 - 74